ONTX - Onconova Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,2287875,54611,456
Cost of Revenue----
Gross Profit1,2287875,54611,456
Operating Expenses
Research Development16,92419,11920,07125,895
Selling General and Administrative7,5867,4059,1789,533
Non Recurring----
Total Operating Expenses24,51026,52429,24935,428
Operating Income or Loss-23,282-25,737-23,703-23,972
Income from Continuing Operations
Total Other Income/Expenses Net2,7481,6584,050-35
Earnings Before Interest and Taxes-23,282-25,737-23,703-23,972
Interest Expense----
Income Before Tax-20,534-24,079-19,653-24,007
Income Tax Expense-124131416
Minority Interest-830830830
Net Income From Continuing Ops-20,410-24,092-19,667-24,023
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-20,573-24,092-19,667-23,979
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-20,573-24,092-19,667-23,979